BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26788980)

  • 1. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
    Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States.
    Chase MR; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
    J Manag Care Spec Pharm; 2016 Jun; 22(6):667-75. PubMed ID: 27231794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time trends in peripheral artery disease incidence, prevalence and secondary preventive therapy: a cohort study in The Health Improvement Network in the UK.
    Cea-Soriano L; Fowkes FGR; Johansson S; Allum AM; García Rodriguez LA
    BMJ Open; 2018 Jan; 8(1):e018184. PubMed ID: 29358428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
    Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
    Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of care for new-onset acute coronary syndrome patients who undergo coronary revascularization.
    McCollam P; Etemad L
    J Invasive Cardiol; 2005 Jun; 17(6):307-11. PubMed ID: 16003005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of dyspnea on medical utilization and affiliated costs in patients with acute coronary syndrome.
    Bonafede M; Jing Y; Gdovin Bergeson J; Liffmann D; Makenbaeva D; Graham J; Deitelzweig SB
    Hosp Pract (1995); 2011 Aug; 39(3):16-22. PubMed ID: 21881388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B; Henriksson M; Lundin F; Wahlberg E
    Eur J Cardiovasc Prev Rehabil; 2011 Apr; 18(2):254-61. PubMed ID: 21450673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China.
    He X; Wang Y; Cong H; Lu C; Wu J
    Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary artery bypass graft surgery in acute coronary syndrome: incidence, cost impact, and acute clopidogrel interruption.
    Johnston SS; Bell K; Gdovin J; Jing Y; Graham J
    Hosp Pract (1995); 2012 Feb; 40(1):15-23. PubMed ID: 22406879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S; Patel MR; Kober L; Peterson ED; Jones WS; Gislason GH; Berger J; Torp-Pedersen C; Fosbol EL
    Circulation; 2012 Sep; 126(11):1345-54. PubMed ID: 22874581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term mortality associated with ventricular arrhythmia in patients hospitalized with acute coronary syndrome: findings from the Gulf RACE registry-2.
    Hersi A; Alhabib KF; Alsheikh-Ali AA; Sulaiman K; Alfaleh HF; Alsaif S; Al-Mahmeed W; Asaad N; Amin H; Al-Motarreb A; Al Suwaidi J
    Coron Artery Dis; 2013 Mar; 24(2):160-4. PubMed ID: 23363987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of hospitalization period and five-year follow-up of patients admitted with acute coronary syndrome following coronary artery bypass graft surgery].
    Can LH; Kayıkçıoğlu M; Yavuzgil O; Kültürsay H; Soydan I
    Turk Kardiyol Dern Ars; 2010 Sep; 38(6):387-92. PubMed ID: 21200116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL; Chow KL; Looi JL; Lee M; Halliday S; White H; Ellis C
    N Z Med J; 2011 Sep; 124(1343):18-27. PubMed ID: 21964009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: results from the antiplatelet treatment observational registries (APTOR).
    Zeymer U; Berkenboom G; Coufal Z; Belger M; Sartral M; Norrbacka K; Bakhai A;
    Int J Cardiol; 2013 Dec; 170(2):239-45. PubMed ID: 24225199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pharmacist-initiated interventions in improving acute coronary syndrome secondary prevention pharmacotherapy prescribing upon discharge.
    Hassan Y; Kassab Y; Abd Aziz N; Akram H; Ismail O
    J Clin Pharm Ther; 2013 Apr; 38(2):97-100. PubMed ID: 23441979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Chen DC; Singh GD; Armstrong EJ; Waldo SW; Laird JR; Amsterdam EA
    Am J Cardiol; 2017 Apr; 119(8):1146-1152. PubMed ID: 28259239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.